Finished product reference

Magnesium Hydroxide

Suspension · Oral · 8 % · 240 mL

List code
777
0

Indications

Uses As an Antacid • heartburn • upset/sour stomach • acid indigestion As a Laxative (usually within ½ to 6 hours) • occasional constipation (irregularity)

Dosage and administration (summary)

Directions As an Antacid • do not exceed the maximum recommended daily dose in a 24 hour period • shake well before use • can be taken with water • mL = milliliter adults and children 12 years of age and over 5 to 15 mL (1 to 3 teaspoonfuls) children under 12 years of age ask a doctor As a Laxative • do not exceed the maximum recommended daily dose of 60 mL in a 24 hour period • shake well before use • dose may be taken once a day preferably at bedtime, in divided doses, or as directed by a doctor. Drink a full glass (8 oz) of liquid with each dose. • mL = milliliter.

Warnings and precautions

Warnings Ask a doctor before use if you have • kidney disease • a magnesium-restricted diet • stomach pain, nausea, or vomiting • a sudden change in bowel habits that lasts over 14 days Ask a doctor or pharmacist before use If you are taking a prescription drug. This product may interact with certain prescription drugs. Stop use and ask a doctor if • you have rectal bleeding or no bowel movement after using this product. These could be signs of a serious condition. • you need to use a laxative for more than 1 week If pregnant or breast-feeding, ask a health professional before use.

Storage and supply

Other information • each teaspoonful (5 mL) contains: magnesium 400 mg • store at room temperature, 20° - 25°C (68° - 77°F). Avoid freezing. • Milk of Magnesia USP (white suspension, spearmint flavor) is supplied in the following oral dosage form: Overbagged with 5 x 30 mL unit dose cup in each bag, NDC 55154-9403-5 WARNING: This Unit Dose package …

Source: Magnesium Hydroxide (Milk Of Magnesia) — US FDA prescribing information, 2026-06-05, DailyMed. Summarised and shortened; the full label governs. Iranian registration, indications and labelling may differ.

Reference information for professional sourcing and registration enquiries, not medical advice or a promotion. Drug information is condensed from US FDA prescribing information (public domain, via openFDA and DailyMed) and does not replace the product’s approved labelling in Iran. Availability, origin and documentation are confirmed per enquiry.

Tell us the quantity, the market and the timing.

Send the molecule or ingredient, the specification and the destination. We reply from Tehran with the questions, the documents and the next step.

Telephone+98 21 8888 3325 · office hours 09:00–17:00, Tehran
OfficeHaniya Parsan Darou, 3rd floor, No. 326, Zafar Street, Africa Boulevard, Tehran 1968734974, Iran
Emailcontact@hanpars.com